The study was led by Jordi Gracia Sancho, the head of the IDIBAPS group Liver vascular biology and a researcher at CIBEREHD. The first authors are Da1
A study promoted by SOLTI and published in Nature Communications describes the tumour biology associated with the activity of the drug patritumab der1
The document is aimed at professionals who conduct any type of biomedical research, and aims to improve the quality of the research being carried out1
There are plans to locate several research groups in Barcelona Science Park’s (PCB) facilities, in a new measure to deal with the institution’s space1
It was observed that the lifeguards received over 20 times the safe dose of UV radiation in a single day. The study results allowed the observation c1
The selected projects were coordinated by Manel Juan, head of the Immunogenetics and Immunotherapy in Autoinflammatory and Immune Responses group and1
This is confirmed by a study conducted by IDIBAPS-Hospital Clínic Barcelona and IDIAPJGol and published in the journal Frontiers in Endocrinology.
This year, FERO will contribute €200,000, with which it will seek to provide structural and sustained support for the Molecular Diagnostics Programme1
IDIBAPS successfully and positively achieved its first reaccreditation in 2014, and its second in 2019.
On 27 June 2024, a social return event was held at the TV3 facilities, thanking the public for the television marathon devoted to cancer.